Eyasu H Teshale

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Environmental sampling for spores of Bacillus anthracis
    Eyasu H Teshale
    Centers for Desease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:1083-7. 2002
  2. ncbi Genotypic distribution of hepatitis B virus (HBV) among acute cases of HBV infection, selected United States counties, 1999-2005
    Eyasu H Teshale
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, TB and STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 53:751-6. 2011
  3. ncbi The two faces of hepatitis E virus
    Eyasu H Teshale
    National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 51:328-34. 2010
  4. ncbi Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda
    Eyasu H Teshale
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Atlanta, Georgia 301333, USA
    Clin Infect Dis 50:1006-10. 2010
  5. ncbi Hepatitis E epidemic, Uganda
    Eyasu H Teshale
    Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G37, Atlanta, GA 30333, USA
    Emerg Infect Dis 16:126-9. 2010
  6. ncbi Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003
    Eyasu H Teshale
    Centers for Disease Control and Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Division of HIV AIDS Prevention, Atlanta, GA, USA
    Vaccine 26:5830-4. 2008
  7. ncbi Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003
    Eyasu H Teshale
    Division of HIV/AIDS Prevention, National Center for HIV, Sexually Transmitted Disease, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 44:879-83. 2007
  8. ncbi Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy
    Patrick S Sullivan
    Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Division of HIV AIDS Prevention, Surveillance and Epidemiology, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    AIDS 20:1171-9. 2006
  9. ncbi Hepatitis A among international adoptees and their contacts
    Gayle E Fischer
    Viral Hepatitis, STD and TB Prevention, National Center for HIV AIDS, Detection and Control of Infectious Diseases, Centers for Disease Control, Atlanta, Georgia 30333, USA
    Clin Infect Dis 47:812-4. 2008
  10. ncbi Persistence of long-term immunity to hepatitis B among adolescents immunized at birth
    Sandra S Chaves
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 30:1644-9. 2012

Collaborators

Detail Information

Publications16

  1. ncbi Environmental sampling for spores of Bacillus anthracis
    Eyasu H Teshale
    Centers for Desease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 8:1083-7. 2002
    ..These results suggest cross-contaminated mail as a possible source of anthrax for the inhalational anthrax patient in Connecticut. In future such investigations, extensive sampling guided by epidemiologic data is imperative...
  2. ncbi Genotypic distribution of hepatitis B virus (HBV) among acute cases of HBV infection, selected United States counties, 1999-2005
    Eyasu H Teshale
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, TB and STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 53:751-6. 2011
    ..In the United States, HBV genotyping studies have been conducted for chronic but not acute hepatitis B...
  3. ncbi The two faces of hepatitis E virus
    Eyasu H Teshale
    National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 51:328-34. 2010
    ....
  4. ncbi Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda
    Eyasu H Teshale
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Atlanta, Georgia 301333, USA
    Clin Infect Dis 50:1006-10. 2010
    ..Outbreaks of infection with hepatitis E virus (HEV) are frequently attributed to contaminated drinking water, even if direct evidence for this is lacking...
  5. ncbi Hepatitis E epidemic, Uganda
    Eyasu H Teshale
    Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G37, Atlanta, GA 30333, USA
    Emerg Infect Dis 16:126-9. 2010
    ..This outbreak has progressed to become one of the largest hepatitis E outbreaks in the world. By June 2009, the epidemic had caused illness in >10,196 persons and 160 deaths...
  6. ncbi Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003
    Eyasu H Teshale
    Centers for Disease Control and Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Division of HIV AIDS Prevention, Atlanta, GA, USA
    Vaccine 26:5830-4. 2008
    ..However, PPV-23 provided no benefit when patients were vaccinated at HIV viral load > 100,000 copies/ml, irrespective of CD4 count at vaccination. Receipt of PPV-23 was associated with lower incidence of all-cause pneumonia...
  7. ncbi Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003
    Eyasu H Teshale
    Division of HIV/AIDS Prevention, National Center for HIV, Sexually Transmitted Disease, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 44:879-83. 2007
  8. ncbi Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy
    Patrick S Sullivan
    Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Division of HIV AIDS Prevention, Surveillance and Epidemiology, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    AIDS 20:1171-9. 2006
    ..To describe the effect of hepatitis C virus (HCV) on the progression of HIV disease and on early changes in the CD4 cell count and HIV viral load after HAART initiation...
  9. ncbi Hepatitis A among international adoptees and their contacts
    Gayle E Fischer
    Viral Hepatitis, STD and TB Prevention, National Center for HIV AIDS, Detection and Control of Infectious Diseases, Centers for Disease Control, Atlanta, Georgia 30333, USA
    Clin Infect Dis 47:812-4. 2008
    ..Most cases occurred among nontraveling contacts of adoptees, suggesting the need to extend prevention guidelines to include hepatitis A vaccination for at-risk nontravelers...
  10. ncbi Persistence of long-term immunity to hepatitis B among adolescents immunized at birth
    Sandra S Chaves
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 30:1644-9. 2012
    ..Future vaccine recommendations should be based on studies ascertaining protection against clinically significant disease...
  11. ncbi Acute hepatitis associated with autochthonous hepatitis E virus infection--San Antonio, Texas, 2009
    Rania A Tohme
    Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 53:793-6. 2011
    ..Hepatitis E virus genotype 3a related to US-2 and swine hepatitis E virus strains was isolated from one of the patients, indicating potential food-borne or zoonotic transmission...
  12. ncbi Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002
    Kathleen M Gallagher
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 196:339-46. 2007
    ..The objectives of the present study were to assess trends in influenza vaccination coverage in HIV-infected patients and to determine predictors of influenza vaccination...
  13. ncbi Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children
    Gregory A Raczniak
    Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Centre Drive, Anchorage, AK 99508, USA Epidemic Intelligence Service, Division of Applied Sciences, Scientific Education and Professional Development Program Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA Electronic address
    Vaccine 31:2152-5. 2013
    ..The hepatitis A vaccine is highly effective but the duration of protection is unknown...
  14. ncbi Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: association of detectable residual antibodies and response to a single HBV challenge dose
    Philip R Spradling
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Vaccine Immunol 20:559-61. 2013
    ..001). The presence of any detectable anti-HBsAg among persons vaccinated in the remote past may indicate the persistence of immune memory...
  15. ncbi Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey
    R Monina Klevens
    Centers for Disease Control and Prevention, Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Rd NE, MS G 37, Atlanta, GA 30333, USA
    Public Health Rep 126:522-32. 2011
    ..We described seroprevalence of antibody to hepatitis A virus (anti-HAV) in the United States during 1999-2006 and compared it with seroprevalence before the availability of vaccine...
  16. ncbi Hepatitis E: Epidemiology and prevention
    Eyasu H Teshale
    Eyasu H Teshale, Dale J Hu, Division of Viral Hepatitis, Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, TB Prevention, Atlanta, GA 30333, United States
    World J Hepatol 3:285-91. 2011
    ..Although there are vaccine candidates that had been shown to be safe and efficacious in clinical trials, none are approved currently for use. There is no specific therapy for acute hepatitis E as treatment remains supportive...